Otsuka Holdings Co., Ltd. (OTSKY)
OTCMKTS
· Delayed Price · Currency is USD
25.42
-0.12 (-0.47%)
Jan 23, 2025, 3:53 PM EST
Otsuka Holdings Revenue
Otsuka Holdings had revenue of 621.15B JPY in the quarter ending September 30, 2024, with 16.86% growth. This brings the company's revenue in the last twelve months to 2.27T, up 16.33% year-over-year. In the year 2023, Otsuka Holdings had annual revenue of 2.02T with 16.14% growth.
Revenue (ttm)
2,269.56B JPY
Revenue Growth
+16.33%
P/S Ratio
n/a
Revenue / Employee
66.00M JPY
Employees
34,388
Market Cap
27.37B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2,018.57B | 280.57B | 16.14% |
| Dec 31, 2022 | 1,738.00B | 239.72B | 16.00% |
| Dec 31, 2021 | 1,498.28B | 75.45B | 5.30% |
| Dec 31, 2020 | 1,422.83B | 26.59B | 1.90% |
| Dec 31, 2019 | 1,396.24B | 104.26B | 8.07% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| Veradigm | 1.53B |
| SS Innovations International | 16.04M |
| Elite Pharmaceuticals | 71.17M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| BioStem Technologies | 210.49M |
| Silence Therapeutics | 21.77M |
Otsuka Holdings News
- 3 months ago - Otsuka Holdings Co., Ltd. reports Q3 results - Seeking Alpha
- 3 months ago - Otsuka Is Said to Weigh Sale of Stake in Medical Device Maker MicroPort Scientific - BNN Bloomberg